Sauer JM - Search Results

1

Atomoxetine hydrochloride: clinical drug-drug interaction prediction and outcome.

Sauer JM, Long AJ, Ring B, Gillespie JS, Sanburn NP, DeSante KA, Petullo D, VandenBranden MR, Jensen CB, Wrighton SA, Smith BP, Read HA, Witcher JW. Sauer JM, et al. J Pharmacol Exp Ther. 2004 Feb;308(2):410-8. doi: 10.1124/jpet.103.058727. Epub 2003 Nov 10. J Pharmacol Exp Ther. 2004. PMID: 14610241

2

Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics.

Belle DJ, Ernest CS, Sauer JM, Smith BP, Thomasson HR, Witcher JW. Belle DJ, et al. Among authors: sauer jm. J Clin Pharmacol. 2002 Nov;42(11):1219-27. doi: 10.1177/009127002762491307. J Clin Pharmacol. 2002. PMID: 12412820 Clinical Trial.

3

Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism.

Sauer JM, Ponsler GD, Mattiuz EL, Long AJ, Witcher JW, Thomasson HR, Desante KA. Sauer JM, et al. Drug Metab Dispos. 2003 Jan;31(1):98-107. doi: 10.1124/dmd.31.1.98. Drug Metab Dispos. 2003. PMID: 12485958

4

Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites.

Chalon SA, Desager JP, Desante KA, Frye RF, Witcher J, Long AJ, Sauer JM, Golnez JL, Smith BP, Thomasson HR, Horsmans Y. Chalon SA, et al. Among authors: sauer jm. Clin Pharmacol Ther. 2003 Mar;73(3):178-91. doi: 10.1067/mcp.2003.25. Clin Pharmacol Ther. 2003. PMID: 12621383

5

Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder.

Witcher JW, Long A, Smith B, Sauer JM, Heilgenstein J, Wilens T, Spencer T, Biederman J. Witcher JW, et al. Among authors: sauer jm. J Child Adolesc Psychopharmacol. 2003 Spring;13(1):53-63. doi: 10.1089/104454603321666199. J Child Adolesc Psychopharmacol. 2003. PMID: 12804126 Clinical Trial.

6

Clinical pharmacokinetics of atomoxetine.

Sauer JM, Ring BJ, Witcher JW. Sauer JM, et al. Clin Pharmacokinet. 2005;44(6):571-90. doi: 10.2165/00003088-200544060-00002. Clin Pharmacokinet. 2005. PMID: 15910008 Review.

7

Disposition and metabolic fate of atomoxetine hydrochloride: pharmacokinetics, metabolism, and excretion in the Fischer 344 rat and beagle dog.

Mattiuz EL, Ponsler GD, Barbuch RJ, Wood PG, Mullen JH, Shugert RL, Li Q, Wheeler WJ, Kuo F, Conrad PC, Sauer JM. Mattiuz EL, et al. Among authors: sauer jm. Drug Metab Dispos. 2003 Jan;31(1):88-97. doi: 10.1124/dmd.31.1.88. Drug Metab Dispos. 2003. PMID: 12485957

8

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.

Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB, Felder CC. Porter AC, et al. Among authors: sauer jm. J Pharmacol Exp Ther. 2002 Jun;301(3):1020-4. doi: 10.1124/jpet.301.3.1020. J Pharmacol Exp Ther. 2002. PMID: 12023533

9

Simultaneous quantification of atomoxetine as well as its primary oxidative and O-glucuronide metabolites in human plasma and urine using liquid chromatography tandem mass spectrometry (LC/MS/MS).

Mullen JH, Shugert RL, Ponsler GD, Li Q, Sundaram B, Coales HL, Yakupkovic JE, Lelacheur RM, Wheeler WJ, Belas FJ, Sauer JM. Mullen JH, et al. Among authors: sauer jm. J Pharm Biomed Anal. 2005 Jul 15;38(4):720-33. doi: 10.1016/j.jpba.2005.02.007. J Pharm Biomed Anal. 2005. PMID: 15967301

10

Cytotoxicity and genotoxicity of methyleugenol and related congeners-- a mechanism of activation for methyleugenol.

Burkey JL, Sauer JM, McQueen CA, Sipes IG. Burkey JL, et al. Among authors: sauer jm. Mutat Res. 2000 Sep 20;453(1):25-33. doi: 10.1016/s0027-5107(00)00070-1. Mutat Res. 2000. PMID: 11006409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page